Lifecore Biomedical, Inc. De (LFCR) Current Assets (2011 - 2025)

Lifecore Biomedical's Current Assets history runs 15 years deep, the most recent figure standing at $85.7 million for Q2 2025.

• In Q2 2025, Current Assets rose 5.73% year-over-year to $85.7 million; the TTM figure through May 2025 stood at $85.7 million (up 5.73% YoY), while the FY2025 annual figure was $85.7 million, up 5.73% from the prior year.
• Current Assets was $85.7 million for Q2 2025 at Lifecore Biomedical, up from $84.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $158.3 million in Q1 2021 to a low of $74.2 million in Q3 2024.
• Historically, Current Assets has averaged $104.7 million across 5 years, with a median of $89.8 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Assets slumped 35.58% in 2023, then increased 10.58% in 2025.
• A 5-year view of Current Assets shows it stood at $150.6 million in 2021, then slipped by 20.9% to $119.1 million in 2022, then plunged by 35.58% to $76.7 million in 2023, then grew by 6.71% to $81.9 million in 2024, then grew by 4.67% to $85.7 million in 2025.
• The last three Current Assets figures came in at $85.7 million (Q2 2025), $84.2 million (Q1 2025), and $81.9 million (Q4 2024), per Business Quant data.